Variable | Cases (48) | Univariate | Multivariate | |||||
---|---|---|---|---|---|---|---|---|
Death | Survival | OR | IC95 % | P | OR | IC95 % | p | |
N (%) | N (%) | |||||||
Male gender | 10 (34.5) | 19 (65.5) | 0.90 | 0.27–3.02 | 1.00 | |||
ICU | 4 (57.1) | 3 (42.9) | 2.87 | 0.56–14.73 | 0.23 | |||
HAIs | 10 (52.6) | 9 (47.4) | 3.49 | 1.01–12.05 | 0.06 | |||
Charlson ≥ 3 | 5 (29.4) | 12 (70.6) | 0.66 | 0.18–2.35 | 0.75 | |||
Co-morb (liver disease) | 0 | 0 | ||||||
Co-morb (cancer) | 1 (50.0) | 1 (50.0) | 1.87 | 0.11–32.01 | 1.00 | |||
Co-morbidities (≥2) | 1 (20.0) | 4 (80.0) | 0.42 | 0.04–4.11 | 0.64 | |||
Deceased donor | 11 (47.8) | 12 (52.2) | 2.90 | 0.85–9.93 | 0.13 | |||
Induction therapy | 17 (77.3) | 5 (22.7) | 0.60 | 0.47–0.77 | 0.15 | |||
Acute rejection (AR) | 9 (47.4) | 10 (52.6) | 2.36 | 0.70–7.95 | 0.22 | |||
AR-corticosteroids | 9 (50.0) | 9 (50.0) | 2.75 | 0.80–9.39 | 0.13 | |||
OB-MMF | 1 (11.1) | 8 (88.9) | 0.18 | 0.02–1.58 | 0.13 | |||
OB-Ciclosporine | 8 (23.5) | 26 (76.5) | 0.17 | 0.04–0.66 | 0.02 | 0.20 | 0.03–1.19 | 0.08 |
Double-J | 1 (100.0) | 0 (0) | 0.34 | 0.23–0.51 | 0.35 | |||
Pre tx dialysis | 16 (39.0) | 25 (61.0) | 3.84 | 0.42–34.94 | 0.40 | |||
CMV | 1 (33.3) | 2 (66.7) | 0.91 | 0.08–10.79 | 1.00 | |||
Shock | 6 (85.7) | 1 (14.3) | 16.4 | 1.76–151.7 | 0.005 | 1.24 | 0.06–27.37 | 0.89 |
Respiratory failure | 12 (85.7) | 2 (14.3) | 34.8 | 5.91–204.8 | <0.001 | 28.3 | 2.53–317.1 | 0.007 |
Pre tx diabetes | 2 (33.3) | 4 (66.7) | 0.90 | 0.15–5.50 | 1.00 | |||
Inadequate atb | 6 (37.5) | 10 (62.5) | 1.14 | 0.33–4.00 | 1.00 |